Here, we evaluated the efficacy of combining a gp120-binding protein, mD1.22, and a gp41 NHR-binding antibody, D5 scFv, on the inhibition of HIV-1 infection and, importantly, the inactivation of cell-free virions. Here, ITIH4 is linked to HIV-1 infection.